Operating Expenses Summary of Botanix Pharmaceuticals Limited

Botanix Pharmaceuticals Limited's latest annual operating expenses in 2024 was 601.82 Thousand AUD , down -93.83% from previous year.
Botanix Pharmaceuticals Limited's latest quarterly operating expenses in 2024 FY was 9.34 Million AUD , down -4.19% from previous quarter.
Botanix Pharmaceuticals Limited reported a annual operating expenses of 9.74 Million AUD in annual operating expenses 2023, down -38.28% from previous year.
Botanix Pharmaceuticals Limited reported a annual operating expenses of 15.79 Million AUD in annual operating expenses 2022, up 55.29% from previous year.
Botanix Pharmaceuticals Limited reported a quarterly operating expenses of 9.34 Million AUD for 2024 FY, down -4.19% from previous quarter.
Botanix Pharmaceuticals Limited reported a quarterly operating expenses of 2.5 Million AUD for 2024 Q2, down 0.0% from previous quarter.

Annual Operating Expenses Chart of Botanix Pharmaceuticals Limited (2024 - 1989)

Historical Annual Operating Expenses of Botanix Pharmaceuticals Limited (2024 - 1989)

Year	Operating Expenses	Operating Expenses Growth
2024	601.82 Thousand AUD	-93.83%
2023	9.74 Million AUD	-38.28%
2022	15.79 Million AUD	55.29%
2021	10.17 Million AUD	-57.89%
2020	24.15 Million AUD	10.59%
2019	21.84 Million AUD	68.8%
2018	12.94 Million AUD	169.25%
2017	4.8 Million AUD	197.51%
2016	1.61 Million AUD	190.87%
2015	555.37 Thousand AUD	-75.53%
2014	2.27 Million AUD	36.44%
2013	1.66 Million AUD	11.62%
2012	1.49 Million AUD	-1.93%
2011	1.51 Million AUD	-23.59%
2010	1.98 Million AUD	-37.01%
2009	3.15 Million AUD	-0.45%
2008	3.17 Million AUD	-14.65%
2007	3.71 Million AUD	16.76%
2006	3.18 Million AUD	-1.77%
2005	3.24 Million AUD	75.0%
2004	1.85 Million AUD	-23.63%
2003	2.42 Million AUD	143.96%
2002	994 Thousand AUD	124.89%
2001	441.99 Thousand AUD	112.95%
2000	-3.41 Million AUD	56.72%
1999	-7.88 Million AUD	51.95%
1998	-16.41 Million AUD	-231.99%
1997	12.43 Million AUD	-1.57%
1996	12.63 Million AUD	66.67%
1995	7.58 Million AUD	18.53%
1994	6.39 Million AUD	24.87%
1993	5.12 Million AUD	32.11%
1992	3.87 Million AUD	27.28%
1991	3.04 Million AUD	4.71%
1990	2.9 Million AUD	2.47%
1989	2.83 Million AUD	0.0%

Year	Operating Expenses	Operating Expenses Growth
2024 Q4	7.84 Million AUD	0.0%
2024 FY	9.34 Million AUD	-4.19%
2024 Q2	2.5 Million AUD	0.0%
2023 Q2	7.42 Million AUD	0.0%
2023 FY	9.74 Million AUD	-38.28%
2023 Q4	2.32 Million AUD	0.0%
2022 Q2	6.45 Million AUD	0.0%
2022 FY	15.79 Million AUD	55.29%
2022 Q4	9.34 Million AUD	0.0%
2021 Q4	3.95 Million AUD	0.0%
2021 FY	10.17 Million AUD	-57.89%
2021 Q2	6.22 Million AUD	0.0%
2020 Q2	14.48 Million AUD	0.0%
2020 Q4	9.66 Million AUD	0.0%
2020 FY	24.15 Million AUD	10.59%
2019 Q4	12.92 Million AUD	0.0%
2019 FY	21.84 Million AUD	68.8%
2019 Q2	1.26 Million AUD	0.0%
2018 FY	12.94 Million AUD	169.25%
2018 Q2	867 Thousand AUD	0.0%
2018 Q4	966.96 Thousand AUD	0.0%
2017 Q4	676.38 Thousand AUD	0.0%
2017 Q2	489.46 Thousand AUD	0.0%
2017 FY	4.8 Million AUD	197.51%
2016 Q1	102.16 Thousand AUD	0.0%
2016 Q2	163.57 Thousand AUD	60.12%
2016 Q4	1.69 Million AUD	320.83%
2016 FY	1.61 Million AUD	190.87%
2016 Q3	403.86 Thousand AUD	146.89%
2015 Q2	102.16 Thousand AUD	-33.15%
2015 Q3	102.16 Thousand AUD	0.0%
2015 FY	555.37 Thousand AUD	-75.53%
2015 Q4	- AUD	-100.0%
2015 Q1	152.81 Thousand AUD	0.0%
2014 Q2	152.81 Thousand AUD	102.01%
2014 Q3	152.81 Thousand AUD	0.0%
2014 Q1	75.64 Thousand AUD	0.0%
2014 Q4	- AUD	-100.0%
2014 FY	2.27 Million AUD	36.44%
2013 Q1	72.42 Thousand AUD	0.0%
2013 Q3	75.64 Thousand AUD	0.0%
2013 FY	1.66 Million AUD	11.62%
2013 Q2	75.64 Thousand AUD	4.45%
2013 Q4	- AUD	-100.0%
2012 Q4	- AUD	-100.0%
2012 Q2	72.42 Thousand AUD	-4.91%
2012 Q3	72.42 Thousand AUD	0.0%
2012 Q1	76.16 Thousand AUD	0.0%
2012 FY	1.49 Million AUD	-1.93%
2011 FY	1.51 Million AUD	-23.59%
2011 Q3	76.16 Thousand AUD	0.0%
2011 Q2	76.16 Thousand AUD	-49.62%
2011 Q1	151.16 Thousand AUD	0.0%
2011 Q4	- AUD	-100.0%
2010 FY	1.98 Million AUD	-37.01%
2010 Q4	- AUD	-100.0%
2010 Q3	151.16 Thousand AUD	0.0%
2010 Q2	151.16 Thousand AUD	-49.78%
2010 Q1	301 Thousand AUD	0.0%
2009 FY	3.15 Million AUD	-0.45%
2009 Q1	220.15 Thousand AUD	0.0%
2009 Q4	- AUD	-100.0%
2009 Q3	301 Thousand AUD	0.0%
2009 Q2	301 Thousand AUD	36.72%
2008 FY	3.17 Million AUD	-14.65%
2008 Q4	- AUD	-100.0%
2008 Q3	220.15 Thousand AUD	0.0%
2008 Q2	220.15 Thousand AUD	-0.06%
2008 Q1	220.28 Thousand AUD	0.0%
2007 Q3	220.28 Thousand AUD	0.0%
2007 Q4	- AUD	-100.0%
2007 Q2	220.28 Thousand AUD	315.49%
2007 Q1	53.01 Thousand AUD	0.0%
2007 FY	3.71 Million AUD	16.76%
2006 FY	3.18 Million AUD	-1.77%
2006 Q3	53.01 Thousand AUD	0.0%
2006 Q4	- AUD	-100.0%
2006 Q2	53.01 Thousand AUD	-78.27%
2006 Q1	244.03 Thousand AUD	0.0%
2005 Q2	244.03 Thousand AUD	37.27%
2005 FY	3.24 Million AUD	75.0%
2005 Q1	177.77 Thousand AUD	0.0%
2005 Q4	- AUD	-100.0%
2005 Q3	244.03 Thousand AUD	0.0%
2004 Q4	- AUD	-100.0%
2004 Q2	177.77 Thousand AUD	-29.3%
2004 Q1	251.46 Thousand AUD	0.0%
2004 FY	1.85 Million AUD	-23.63%
2004 Q3	177.77 Thousand AUD	0.0%
2003 FY	2.42 Million AUD	143.96%
2003 Q3	251.46 Thousand AUD	0.0%
2003 Q1	37.31 Thousand AUD	0.0%
2003 Q4	- AUD	-100.0%
2003 Q2	251.46 Thousand AUD	573.87%
2002 Q2	37.31 Thousand AUD	-54.11%
2002 Q4	- AUD	-100.0%
2002 FY	994 Thousand AUD	124.89%
2002 Q3	37.31 Thousand AUD	0.0%
2002 Q1	81.31 Thousand AUD	0.0%
2001 Q3	81.31 Thousand AUD	0.0%
2001 Q2	81.31 Thousand AUD	104.94%
2001 Q4	- AUD	-100.0%
2001 Q1	-1.64 Million AUD	0.0%
2001 FY	441.99 Thousand AUD	112.95%
2000 Q2	-1.64 Million AUD	17.4%
2000 FY	-3.41 Million AUD	56.72%
2000 Q4	- AUD	100.0%
2000 Q3	-1.64 Million AUD	0.0%
2000 Q1	-1.99 Million AUD	0.0%
1999 Q1	-4.08 Million AUD	0.0%
1999 Q4	- AUD	100.0%
1999 FY	-7.88 Million AUD	51.95%
1999 Q2	-1.99 Million AUD	51.18%
1999 Q3	-1.99 Million AUD	0.0%
1998 FY	-16.41 Million AUD	-231.99%
1998 Q1	235.5 Thousand AUD	0.0%
1998 Q3	-4.08 Million AUD	0.0%
1998 Q2	-4.08 Million AUD	-1833.55%
1998 Q4	-4.08 Million AUD	0.0%
1997 Q4	- AUD	-100.0%
1997 FY	12.43 Million AUD	-1.57%
1997 Q1	3.15 Million AUD	0.0%
1997 Q2	235.5 Thousand AUD	-92.54%
1997 Q3	235.5 Thousand AUD	0.0%
1996 Q2	3.15 Million AUD	66.67%
1996 Q4	3.15 Million AUD	0.0%
1996 FY	12.63 Million AUD	66.67%
1996 Q1	1.89 Million AUD	0.0%
1996 Q3	3.15 Million AUD	0.0%
1995 FY	7.58 Million AUD	18.53%
1995 Q1	1.59 Million AUD	0.0%
1995 Q4	1.89 Million AUD	0.0%
1995 Q3	1.89 Million AUD	0.0%
1995 Q2	1.89 Million AUD	18.53%
1994 Q2	1.59 Million AUD	24.87%
1994 FY	6.39 Million AUD	24.87%
1994 Q4	1.59 Million AUD	0.0%
1994 Q3	1.59 Million AUD	0.0%
1994 Q1	1.28 Million AUD	0.0%
1993 Q1	969.25 Thousand AUD	0.0%
1993 FY	5.12 Million AUD	32.11%
1993 Q4	1.28 Million AUD	0.0%
1993 Q3	1.28 Million AUD	0.0%
1993 Q2	1.28 Million AUD	32.11%
1992 Q2	969.25 Thousand AUD	27.28%
1992 Q1	761.5 Thousand AUD	0.0%
1992 Q3	969.25 Thousand AUD	0.0%
1992 FY	3.87 Million AUD	27.28%
1992 Q4	969.25 Thousand AUD	0.0%
1991 Q4	761.5 Thousand AUD	0.0%
1991 FY	3.04 Million AUD	4.71%
1991 Q1	727.25 Thousand AUD	0.0%
1991 Q2	761.5 Thousand AUD	4.71%
1991 Q3	761.5 Thousand AUD	0.0%
1990 Q1	709.75 Thousand AUD	0.0%
1990 Q2	727.25 Thousand AUD	2.47%
1990 FY	2.9 Million AUD	2.47%
1990 Q3	727.25 Thousand AUD	0.0%
1990 Q4	727.25 Thousand AUD	0.0%
1989 Q3	709.75 Thousand AUD	0.0%
1989 FY	2.83 Million AUD	0.0%
1989 Q4	709.75 Thousand AUD	0.0%
1989 Q2	709.75 Thousand AUD	0.0%

Peer Operating Expenses Comparison of Botanix Pharmaceuticals Limited

Name	Operating Expenses	Operating Expenses Difference
AdAlta Limited	6.76 Million AUD	91.11%
Acrux Limited	8.55 Million AUD	92.961%
Actinogen Medical Limited	22.77 Million AUD	97.357%
AnteoTech Limited	12.18 Million AUD	95.062%
Argenica Therapeutics Limited	8.26 Million AUD	92.722%
Arovella Therapeutics Limited	10.78 Million AUD	94.42%
Anatara Lifesciences Ltd	710.21 Thousand AUD	15.263%
Alterity Therapeutics Limited	23.4 Million AUD	97.429%
Amplia Therapeutics Limited	8.43 Million AUD	92.866%
Avecho Biotechnology Limited	4.54 Million AUD	86.76%
Bio-Gene Technology Limited	2.76 Million AUD	78.203%
Biome Australia Limited	7.91 Million AUD	92.393%
Biotron Limited	5.11 Million AUD	88.224%
BTC Health Limited	-1.03 Million AUD	157.927%
Chimeric Therapeutics Limited	19.76 Million AUD	96.955%
CSL Limited	7.56 Billion AUD	99.992%
Clarity Pharmaceuticals Ltd	56.3 Million AUD	98.931%
Clinuvel Pharmaceuticals Limited	31.29 Million AUD	98.077%
Cynata Therapeutics Limited	11.12 Million AUD	94.59%
Dimerix Limited	25.64 Million AUD	97.653%
EZZ Life Science Holdings Limited	39.57 Million AUD	98.479%
Hexima Limited	1 Million AUD	40.34%
Island Pharmaceuticals Limited	4.12 Million AUD	85.412%
Immuron Limited	9.13 Million AUD	93.414%
Immutep Limited	42.87 Million AUD	98.596%
Imugene Limited	135.09 Million AUD	99.555%
Invex Therapeutics Ltd	3.34 Million AUD	82.013%
Memphasys Limited	3.67 Million AUD	83.639%
Nanollose Limited	12.5 Thousand AUD	-4714.175%
Neuren Pharmaceuticals Limited	32.69 Million AUD	98.159%
Noxopharm Limited	7 Million AUD	91.403%
NeuroScientific Biopharmaceuticals Limited	1.96 Million AUD	69.376%
Nyrada Inc.	4.55 Million AUD	86.788%
Orthocell Limited	15.36 Million AUD	96.084%
PharmAust Limited	6.65 Million AUD	90.96%
Patrys Limited	4.93 Million AUD	87.801%
Paradigm Biopharmaceuticals Limited	65.1 Million AUD	99.076%
Proteomics International Laboratories Limited	892.14 Thousand AUD	32.542%
Prescient Therapeutics Limited	10.89 Million AUD	94.478%
PYC Therapeutics Limited	60.91 Million AUD	99.012%
Race Oncology Limited	14.77 Million AUD	95.926%
Radiopharm Theranostics Limited	299.22 Thousand AUD	-101.124%
Recce Pharmaceuticals Ltd	21.68 Million AUD	97.225%
Starpharma Holdings Limited	22.81 Million AUD	97.362%
Telix Pharmaceuticals Limited	269.26 Million AUD	99.776%
Tissue Repair Ltd	6.66 Million AUD	90.973%
Zelira Therapeutics Limited	5.94 Million AUD	89.883%

Global Stocks Search

Botanix Pharmaceuticals Limited (BOT.AX)

Operating Expenses Summary of Botanix Pharmaceuticals Limited

Annual Operating Expenses Chart of Botanix Pharmaceuticals Limited (2024 - 1989)

Historical Annual Operating Expenses of Botanix Pharmaceuticals Limited (2024 - 1989)

Peer Operating Expenses Comparison of Botanix Pharmaceuticals Limited